Saturday, July 11, 2026

pharma · Non Small Cell Lung Cancer

Shanghai General Hospital

Shanghai General Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Non Small Cell Lung Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent reco

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
2
Patents
0
Clinical program

radiochemotherapy 1

Unknown · other · Non Small Cell Lung Cancer

radiochemotherapy 1 for Non Small Cell Lung Cancer is a Unknown program (other) at Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine with 1 ClinicalTrials.gov record(s).

Internal code SGH201708

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase
Unknown
Modality
other
Indication
Non Small Cell Lung Cancer
Status
completed
Trials
1